These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

383 related articles for article (PubMed ID: 20029819)

  • 21. Mutations associated with lamivudine-resistance in therapy-naïve hepatitis B virus (HBV) infected patients with and without HIV co-infection: implications for antiretroviral therapy in HBV and HIV co-infected South African patients.
    Selabe SG; Lukhwareni A; Song E; Leeuw YG; Burnett RJ; Mphahlele MJ
    J Med Virol; 2007 Nov; 79(11):1650-4. PubMed ID: 17854040
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Evaluation of chronic hepatitis B virus (HBV) infection in coinfected patients receiving lamivudine as a component of anti-human immunodeficiency virus regimens.
    Hoff J; Bani-Sadr F; Gassin M; Raffi F
    Clin Infect Dis; 2001 Mar; 32(6):963-9. PubMed ID: 11247719
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Reactivation of lamivudine-resistant occult hepatitis B in an HIV-infected patient undergoing cytotoxic chemotherapy.
    Schnepf N; Sellier P; Bendenoun M; Zini JM; Sanson-le Pors MJ; Mazeron MC
    J Clin Virol; 2007 May; 39(1):48-50. PubMed ID: 17368969
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prevalence of occult hepatitis B virus infection in a general adult population in Korea.
    Song EY; Yun YM; Park MH; Seo DH
    Intervirology; 2009; 52(2):57-62. PubMed ID: 19401629
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hepatitis B virus and human immunodeficiency virus co-infection in sub-Saharan Africa: a call for further investigation.
    Burnett RJ; François G; Kew MC; Leroux-Roels G; Meheus A; Hoosen AA; Mphahlele MJ
    Liver Int; 2005 Apr; 25(2):201-13. PubMed ID: 15780040
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Frequency of isolated hepatitis B core antibody in HIV-hepatitis C virus co-infected individuals.
    Ramezani A; Mohraz M; Aghakhani A; Banifazl M; Eslamifar A; Khadem-Sadegh A; Velayati AA
    Int J STD AIDS; 2009 May; 20(5):336-8. PubMed ID: 19386971
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Detection of HBV-DNA in peripheral blood mononuclear cells of anti-HIV-positive patients and its relation to other serological markers of HBV].
    Suñén E; Malave C; Sarriá L; Gorriño C; Campelo C; Martínez J; Cisterna R
    Enferm Infecc Microbiol Clin; 1992 Oct; 10(8):445-50. PubMed ID: 1489771
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Predictors of hepatitis B virus genotype and viraemia in HIV-infected patients with chronic hepatitis B in Europe.
    Soriano V; Mocroft A; Peters L; Rockstroh J; Antunes F; Kirkby N; de Wit S; Monforte Ad; Flisiak R; Lundgren J;
    J Antimicrob Chemother; 2010 Mar; 65(3):548-55. PubMed ID: 20051475
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Isolated core antibody hepatitis B in sub-Saharan African immigrants.
    Gibney KB; Torresi J; Lemoh C; Biggs BA
    J Med Virol; 2008 Sep; 80(9):1565-9. PubMed ID: 18649341
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hepatitis B virus co-infection in human immunodeficiency virus-infected subjects.
    Puoti M; Airoldi M; Bruno R; Zanini B; Spinetti A; Pezzoli C; Patroni A; Castelli F; Sacchi P; Filice G; Carosi G
    AIDS Rev; 2002; 4(1):27-35. PubMed ID: 11998781
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prevalence and clinical implications of occult hepatitis B viral infection in hemophilia patients in Japan.
    Toyoda H; Hayashi K; Murakami Y; Honda T; Katano Y; Nakano I; Goto H; Kumada T; Takamatsu J
    J Med Virol; 2004 Jun; 73(2):195-9. PubMed ID: 15122792
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Seroepidemiology of hepatitis B, delta and human immunodeficiency virus infections in Hamadan province, Iran: a population based study.
    Amini S; Mahmoodi MF; Andalibi S; Solati AA
    J Trop Med Hyg; 1993 Oct; 96(5):277-87. PubMed ID: 8411302
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Should patients infected with HIV be screened for occult hepatitis B?].
    Marque-Juillet S; Benghalia K; Monnier S; Fernand-Laurent C; Mazeron MC; Harzic M
    Pathol Biol (Paris); 2010 Apr; 58(2):e39-42. PubMed ID: 19854582
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Anti-hepatits B core antigen testing, viral markers, and occult hepatitis B virus infection in Pakistani blood donors: implications for transfusion practice.
    Bhatti FA; Ullah Z; Salamat N; Ayub M; Ghani E
    Transfusion; 2007 Jan; 47(1):74-9. PubMed ID: 17207233
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Study of the impact of HIV genotypic drug resistance testing on therapy efficacy.
    Van Vaerenbergh K
    Verh K Acad Geneeskd Belg; 2001; 63(5):447-73. PubMed ID: 11813503
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Reactivation of hepatitis B virus replication accompanied by acute hepatitis in patients receiving highly active antiretroviral therapy.
    Manegold C; Hannoun C; Wywiol A; Dietrich M; Polywka S; Chiwakata CB; Günther S
    Clin Infect Dis; 2001 Jan; 32(1):144-8. PubMed ID: 11118394
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Impact of highly active antiretroviral therapy (HAART) on the natural history of hepatitis B virus (HBV) and HIV coinfection: relationship between prolonged efficacy of HAART and HBV surface and early antigen seroconversion.
    Miailhes P; Trabaud MA; Pradat P; Lebouché B; Chevallier M; Chevallier P; Zoulim F; Trepo C
    Clin Infect Dis; 2007 Sep; 45(5):624-32. PubMed ID: 17682999
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Long-term incidence of hepatitis B virus resistance to lamivudine in human immunodeficiency virus-infected patients.
    Benhamou Y; Bochet M; Thibault V; Di Martino V; Caumes E; Bricaire F; Opolon P; Katlama C; Poynard T
    Hepatology; 1999 Nov; 30(5):1302-6. PubMed ID: 10534354
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hepatitis B and C viral load changes following initiation of highly active antiretroviral therapy (HAART) in patients with advanced HIV infection.
    Asmuth DM; Busch MP; Laycock ME; Mohr BA; Kalish LA; van der Horst CM;
    Antiviral Res; 2004 Aug; 63(2):123-31. PubMed ID: 15302141
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Anti-hepatitis B virus efficacy of tenofovir disoproxil fumarate in HIV-infected patients.
    Benhamou Y; Fleury H; Trimoulet P; Pellegrin I; Urbinelli R; Katlama C; Rozenbaum W; Le Teuff G; Trylesinski A; Piketty C;
    Hepatology; 2006 Mar; 43(3):548-55. PubMed ID: 16496322
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.